Dr. Emilia Javorsky
👤 SpeakerAppearances Over Time
Podcast Appearances
So on the AI side, we're rapidly scaling and flooding the system with new molecules that we want to test.
But we can't scale people.
We can't scale the number of patients in a clinical trial.
We can't scale the number of tumor specimens that come from a patient to test.
And so that's not actually a scalable model.
And you really need to understand how are we going to allocate this precious resource of patients, of samples that we have that are actually limited and we can't create more of.
And similarly with these diseases that take time to actually test out whether something is working or not, we can't compress time.
You can't scale time.
You can't make a pregnancy go faster.
There's certain fundamental things in biology that just need to take time to understand on that iteration, is this working or not working?
Even when we flood the system, we have to examine what kind of system are we introducing this technology into and what does it incentivize?
And while we call it the healthcare system, it's actually not a system where the incentives are aligned with keeping people healthy or preventing disease.
It's a system where you make more money as a provider or a hospital based on more care that you give.
that's totally decoupled if that care is effective or not, or what the outcomes are.
It's just the more care you give, the more money you get.
And this is where I think the opportunity and the peril for AI in the healthcare system really exists because there are ways that we could leverage these AI tools that we have today to completely redesign the system and redesign the structures and enable new ways of incentivizing the things that we actually want.
So I think the example of United and healthcare, there's so many middlemen in healthcare that are not actually the person taking care of the patient.
And if you look at from health insurers to pharmaceutical benefit managers, the administrative waste estimated in healthcare is huge.
Somewhere between 30 or 40% by some estimates.
It's up there, right?